Evidence Creation

Odelle Technology supports health-technology companies in designing evidence-generation strategies that are relevant to reimbursement, HTA, payer evaluation, hospital adoption and commercial scale-up. The service is suitable for medtech, in vitro diagnostics, digital health, AI-enabled healthcare, biotech, pharma, companion diagnostics, surgical technologies and implantable devices.  Odelle helps companies move from technical or clinical promise to evidence that decision-makers can use. This may include defining the target patient population, comparator, clinical claim, evidence gaps, endpoint hierarchy, real-world evidence requirements, PMCF alignment, patient-reported outcomes, resource-use measures, budget-impact inputs and health-economic evidence architecture.  The service may support pre-CE evidence planning, clinical validation, post-market follow-up, registry design, pilot study preparation, payer-facing evidence packages and evidence-to-reimbursement roadmaps. Odelle does not conduct clinical trials directly, but helps companies design evidence frameworks that align with the expectations of HTA bodies, payers, hospitals, insurers, investors and reimbursement authorities.  Typical outputs may include an evidence-gap assessment, payer-relevant endpoint map, clinical utility framework, RWE or registry evidence plan, health-economic evidence requirements, country-specific evidence expectations and a board-ready evidence-generation roadmap. The objective is to ensure that evidence is not only scientifically credible, but also useful for reimbursement, pricing, adoption and long-term market access.